{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20180430",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "53983",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019356s008,019599s014,204286s003lbl.pdf",
              "date": "20180502",
              "type": "Label"
            },
            {
              "id": "53992",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/019356Orig1s008,019599Orig1s014,204286Orig1s003ltr.pdf",
              "date": "20180503",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20141010",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "19541",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204286s001lbl.pdf",
              "date": "20141015",
              "type": "Label"
            },
            {
              "id": "32538",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204286Orig1s001ltr.pdf",
              "date": "20141014",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20130627",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "40371",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204286s000lbl.pdf",
              "date": "20130711",
              "type": "Label"
            },
            {
              "id": "43460",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204286_naftin_toc.html",
              "date": "20131003",
              "type": "Review"
            },
            {
              "id": "51444",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/204286 nafttifine clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "51445",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/204286 naftifine clinpharm prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "24464",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204286Orig1s000SumR.pdf",
              "date": "20131003",
              "type": "Summary Review"
            },
            {
              "id": "32537",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204286Orig1s000ltr.pdf",
              "date": "20130701",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20200409",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "62528",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/204286Orig1s004ltr.pdf",
              "date": "20200410",
              "type": "Letter"
            },
            {
              "id": "62578",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204286s004lbl.pdf",
              "date": "20200415",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20140924",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "32539",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204286Orig1s002ltr.pdf",
              "date": "20140925",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA204286",
      "sponsor_name": "LEGACY",
      "openfda": {
        "application_number": [
          "NDA204286"
        ],
        "brand_name": [
          "NAFTIN"
        ],
        "generic_name": [
          "NAFTIFINE HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Legacy Pharma USA Inc.",
          "Sebela Pharmaceuticals Inc."
        ],
        "product_ndc": [
          "83107-023",
          "54766-772"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TOPICAL"
        ],
        "substance_name": [
          "NAFTIFINE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1433734",
          "1433736"
        ],
        "spl_id": [
          "3b299c91-fdf6-726c-e063-6394a90ad77b",
          "43150f38-df38-5e12-e063-6294a90a1128"
        ],
        "spl_set_id": [
          "6c6ee055-4031-45a7-8561-ccd989343580",
          "6645994a-ecb3-277b-e053-2a91aa0a81e5"
        ],
        "package_ndc": [
          "83107-023-60",
          "83107-023-45",
          "54766-772-60",
          "54766-772-45"
        ],
        "unii": [
          "25UR9N9041"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "NAFTIN",
          "active_ingredients": [
            {
              "name": "NAFTIFINE HYDROCHLORIDE",
              "strength": "2%"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "GEL",
          "route": "TOPICAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}